TAC1 and Schnyder corneal dystrophy: However, attention is necessary because data show that after QST testing in SCD patients, there are changes in pro-inflammatory biomarkers such as increased levels of Interleukin 6 (IL-6), substance P, and tumor necrosis Factor-alpha (TNFα) (33).